Citation: A. Nagyova et al., OXIDATION RESISTANCE OF LDL IN HYPERTRIGLYCERIDEMIC PATIENTS TREATED WITH CIPROFIBRATE, Physiologia bohemoslovaca, 47(3), 1998, pp. 185-190
Authors:
RASLOVA K
SMOLKOVA B
VOHNOUT B
SCHIFFERDECKER B
POLEDNE R
DUSINSKA M
Citation: K. Raslova et al., APOLIPOPROTEIN-E GENOTYPES IN OFFSPRING WITH A POSITIVE AND NEGATIVE FAMILY HISTORY OF PREMATURE MYOCARDIAL-INFARCTION, Clinical genetics, 53(5), 1998, pp. 387-390
Authors:
FRUCHART JC
BREWER B
LEITERSDORF E
BROCHIER M
BROWN G
CALVO C
CARMENA R
CESKA R
LOYSOONG WC
DAVIGNON J
GOTTO A
GRUNDY S
HAMSTEN A
KEECH A
MATSUZAWA Y
PATCH JR
PAOLETTI R
RASLOVA K
SMIRNOV V
STEINER G
THOMPSON G
ZHU JR
Citation: Jc. Fruchart et al., CONSENSUS FOR THE USE OF FIBRATES IN THE TREATMENT OF DYSLIPOPROTEINEMIA AND CORONARY HEART-DISEASE, The American journal of cardiology, 81(7), 1998, pp. 912
Authors:
COLLINS A
DUSINSKA M
FRANKLIN M
SOMOROVSKA M
PETROVSKA H
DUTHIE S
FILLION L
PANAYIOTIDIS M
RASLOVA K
VAUGHAN N
Citation: A. Collins et al., COMET ASSAY IN HUMAN BIOMONITORING STUDIES - RELIABILITY, VALIDATION,AND APPLICATIONS, Environmental and molecular mutagenesis, 30(2), 1997, pp. 139-146
Authors:
RASLOVA K
DUBOVSKA D
MONGIELLOVA V
TRNOVEC T
Citation: K. Raslova et al., RELATIONSHIP BETWEEN PLASMA FENOFIBRIC ACID LEVELS AND THE EFFECT OF MICRONIZED FENOFIBRATE ON CHOLESTEROL, LOW-DENSITY-LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN-B IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, European Journal of Clinical Pharmacology, 52(2), 1997, pp. 101-106
Authors:
RASLOVA K
SMOLKOVA B
FROHLICH JJ
SCHIFFERDECKER B
JAMANI A
VOHNOUT B
DUSINSKA M
SECCOMBE D
Citation: K. Raslova et al., METHYLENETETRAHYDROFOLATE REDUCTASE GENOTYPES IN YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION, Atherosclerosis, 134(1-2), 1997, pp. 167-167
Citation: K. Raslova et M. Huckova, DYSLIPOPROTEINEMIA IN CHILDREN WITH OR WITHOUT FAMILY HISTORY OF PREMATURE MYOCARDIAL-INFARCTION, Physiological Research, 44(6), 1995, pp. 429-432